Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 21 clinical trials
Erenumab For Treatment of Hemicrania Continua

This research is being conducting to learn if the study drug erenumab is successful in treating hemicrania continua. The study is also evaluating the safety and tolerability of erenumab in

  • 0 views
  • 29 Sep, 2021
  • 1 location
Erenumab-aooe for the Management of Trigeminal Neuropathic Pain.

This study is a single center, placebo-controlled, double blind, randomized, phase II pilot to evaluate the efficacy of erenumab-aooe in the management of trigeminal neuropathic pain comparing

  • 0 views
  • 15 May, 2022
  • 1 location
  • 0 views
  • 18 Feb, 2021
  • 3 locations
Effectiveness of a Health Education Programme for Prevention of Chronic Migraine: A Randomized Clinical Trial

Chronic migraine (CM) is a common and frequent disorder, which has a major impact on the quality of life of migraine sufferers, interfering with physical function, productivity at work, personal life and leisure, lifestyle and psychological well-being. The use of a prophylactic drug treatment is recommended if headache is present …

  • 0 views
  • 19 Apr, 2022
  • 1 location
Biomarker and Genetic Predictors of Erenumab Treatment Response

To explore the relationship between clinical response to erenumab and genetic biomarkers

headache
erenumab
  • 0 views
  • 09 Dec, 2021
  • 4 locations
Erenumab - Comprehensive Assessment of Efficacy in (High-Frequency) Episodic Migraine (EMBRACE)

The primary objective of this study is to evaluate the treatment benefit of erenumab on headache duration of at least moderate pain intensity.

moderate pain
erenumab
episodic migraine
headache
  • 359 views
  • 24 Jul, 2022
  • 71 locations
Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic Migraine (OASIS (CM))

This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and adolescents (12 to <18 years) with chronic migraine. The study

chronic migraine
headache
erenumab
  • 422 views
  • 09 Jul, 2022
  • 68 locations
Efficacy and Safety of Erenumab in Pediatric Subjects With Episodic Migraine (OASIS(EM))

This study will evaluate the efficacy and safety of erenumab in migraine prevention in children (6 to <12 years) and adolescents (12 to <18 years) with episodic migraine. The study

phonophobia
episodic migraine
erenumab
photophobia
headache
  • 258 views
  • 09 Aug, 2022
  • 70 locations
Registry for Migraine - Clinical Core

This study aims to investigate the effect of erenumab on efficacy outcomes, tolerability outcomes, and patient-reported outcomes in individuals with migraine. Furthermore, the study aims to

headache
erenumab
  • 0 views
  • 26 Jan, 2021
  • 1 location
MicroRNA Profile and Erenumab Treatment

Erenumab, a monoclonal antibody acting on the calcitonin gene-related peptide (CGRP) receptor, is an effective and safe migraine-specific preventive drug. The use of migraine-specific preventive

calcitonin
episodic migraine
erenumab
chronic migraine
headache
  • 0 views
  • 16 Jul, 2021
  • 1 location